Package 69367-209-01

Brand: acetazolamide

Generic: acetazolamide
NDC Package

Package Facts

Identity

Package NDC 69367-209-01
Digits Only 6936720901
Product NDC 69367-209
Description

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)

Marketing

Marketing Status
Discontinued 2028-05-01
Brand acetazolamide
Generic acetazolamide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c04410c8-e55f-4f15-a10d-9d94476bde16", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0369367209014"], "unii": ["O3FX965V0I"], "rxcui": ["562524"], "spl_set_id": ["417b1df2-63bc-473c-9e02-5f93dd45554d"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01)", "package_ndc": "69367-209-01", "marketing_end_date": "20280501", "marketing_start_date": "20230420"}], "brand_name": "Acetazolamide", "product_id": "69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "69367-209", "generic_name": "Acetazolamide", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "500 mg/1"}], "application_number": "ANDA090779", "marketing_category": "ANDA", "marketing_end_date": "20280501", "marketing_start_date": "20230420"}